Gorman GS - Search Results

1

Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.

Jia L, Gorman GS, Coward LU, Noker PE, McCormick D, Horn TL, Harder JB, Muzzio M, Prabhakar B, Ganesh B, Das Gupta TK, Beattie CW. Jia L, et al. Among authors: gorman gs. Cancer Chemother Pharmacol. 2011 Aug;68(2):513-24. doi: 10.1007/s00280-010-1518-3. Epub 2010 Nov 18. Cancer Chemother Pharmacol. 2011. PMID: 21085965

2

Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys.

Butenhoff JL, Kennedy GL Jr, Hinderliter PM, Lieder PH, Jung R, Hansen KJ, Gorman GS, Noker PE, Thomford PJ. Butenhoff JL, et al. Among authors: gorman gs. Toxicol Sci. 2004 Dec;82(2):394-406. doi: 10.1093/toxsci/kfh302. Epub 2004 Oct 6. Toxicol Sci. 2004. PMID: 15470233

3

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.

Jia L, Tomaszewski JE, Hanrahan C, Coward L, Noker P, Gorman G, Nikonenko B, Protopopova M. Jia L, et al. Br J Pharmacol. 2005 Jan;144(1):80-7. doi: 10.1038/sj.bjp.0705984. Br J Pharmacol. 2005. PMID: 15644871 Free PMC article.

4

Simultaneous estimation of pharmacokinetic properties in mice of three anti-tubercular ethambutol analogs obtained from combinatorial lead optimization.

Jia L, Tomaszewski JE, Noker PE, Gorman GS, Glaze E, Protopopova M. Jia L, et al. Among authors: gorman gs. J Pharm Biomed Anal. 2005 Apr 1;37(4):793-9. doi: 10.1016/j.jpba.2004.11.036. Epub 2004 Dec 25. J Pharm Biomed Anal. 2005. PMID: 15797803

5

Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv.

Jia L, Coward L, Gorman GS, Noker PE, Tomaszewski JE. Jia L, et al. Among authors: gorman gs. J Pharmacol Exp Ther. 2005 Nov;315(2):905-11. doi: 10.1124/jpet.105.087817. Epub 2005 Aug 5. J Pharmacol Exp Ther. 2005. PMID: 16085758

6

Interspecies pharmacokinetics and in vitro metabolism of SQ109.

Jia L, Noker PE, Coward L, Gorman GS, Protopopova M, Tomaszewski JE. Jia L, et al. Among authors: gorman gs. Br J Pharmacol. 2006 Mar;147(5):476-85. doi: 10.1038/sj.bjp.0706650. Br J Pharmacol. 2006. PMID: 16432511 Free PMC article.

7

Quantitative determination of apogossypol, a pro-apoptotic analog of gossypol, in mouse plasma using LC/MS/MS.

Coward L, Gorman G, Noker P, Kerstner-Wood C, Pellecchia M, Reed JC, Jia L. Coward L, et al. J Pharm Biomed Anal. 2006 Nov 16;42(5):581-6. doi: 10.1016/j.jpba.2006.05.020. Epub 2006 Jul 21. J Pharm Biomed Anal. 2006. PMID: 16859853

8

Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.

Jia L, Coward LC, Kerstner-Wood CD, Cork RL, Gorman GS, Noker PE, Kitada S, Pellecchia M, Reed JC. Jia L, et al. Among authors: gorman gs. Cancer Chemother Pharmacol. 2008 Jan;61(1):63-73. doi: 10.1007/s00280-007-0446-3. Epub 2007 Mar 14. Cancer Chemother Pharmacol. 2008. PMID: 17356822

9

Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water.

Chang SC, Das K, Ehresman DJ, Ellefson ME, Gorman GS, Hart JA, Noker PE, Tan YM, Lieder PH, Lau C, Olsen GW, Butenhoff JL. Chang SC, et al. Among authors: gorman gs. Toxicol Sci. 2008 Jul;104(1):40-53. doi: 10.1093/toxsci/kfn057. Epub 2008 Mar 18. Toxicol Sci. 2008. PMID: 18353799

10

Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.

Jia L, Noker PE, Piazza GA, Leuschner C, Hansel W, Gorman GS, Coward LU, Tomaszewski J. Jia L, et al. Among authors: gorman gs. J Pharm Pharmacol. 2008 Nov;60(11):1441-8. doi: 10.1211/jpp.60.11.0004. J Pharm Pharmacol. 2008. PMID: 18957164 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page